-
公开(公告)号:US07183267B2
公开(公告)日:2007-02-27
申请号:US10866179
申请日:2004-06-10
申请人: Ernesto Freire , Patrick Ross , Yingxin Xiao , Raphael Ottenbrite , Irene Luque
发明人: Ernesto Freire , Patrick Ross , Yingxin Xiao , Raphael Ottenbrite , Irene Luque
CPC分类号: A61K31/381 , C07D213/63 , C07D327/04 , C07F5/025 , G01N2800/52
摘要: The invention provides novel non-β-lactam inhibitors of β-lactamases. In particular, the invention provides boronic acid-based compounds set forth in the specification. These compounds may be used with β-lactam antibiotics to bacterial infection, particularly, β-lactam-antibiotic-resistant bacterial infections. These compounds are also antibacterial agents by themselves. The invention further provides methods of using such compounds. Finally, the invention provides a pharmaceutical composition comprising these compounds.
摘要翻译: 本发明提供了β-内酰胺酶的新型非β-内酰胺抑制剂。 特别地,本发明提供了说明书中阐述的基于硼酸的化合物。 这些化合物可以与β-内酰胺抗生素一起用于细菌感染,特别是β-内酰胺抗生素抗性细菌感染。 这些化合物本身也是抗菌剂。 本发明还提供了使用这些化合物的方法。 最后,本发明提供包含这些化合物的药物组合物。
-
公开(公告)号:US20050124580A1
公开(公告)日:2005-06-09
申请号:US10866179
申请日:2004-06-10
申请人: Ernesto Freire , Patrick Ross , Yingxin Xiao , Raphael Ottenbrite , Irene Luque
发明人: Ernesto Freire , Patrick Ross , Yingxin Xiao , Raphael Ottenbrite , Irene Luque
IPC分类号: A61K20060101 , A61K31/381 , A61K31/69 , C07D327/04
CPC分类号: A61K31/381 , C07D213/63 , C07D327/04 , C07F5/025 , G01N2800/52
摘要: The invention provides novel non-β-lactam inhibitors of β-lactamases. In particular, the invention provides boronic acid-based compounds set forth in the specification. These compounds may be used with β-lactam antibiotics to bacterial infection, particularly, β-lactam-antibiotic-resistant bacterial infections. These compounds are also antibacterial agents by themselves. The invention further provides methods of using such compounds. Finally, the invention provides a pharmaceutical composition comprising these compounds.
摘要翻译: 本发明提供了β-内酰胺酶的新型非β-内酰胺抑制剂。 特别地,本发明提供了说明书中阐述的基于硼酸的化合物。 这些化合物可以与β-内酰胺抗生素一起用于细菌感染,特别是β-内酰胺抗生素抗性细菌感染。 这些化合物本身也是抗菌剂。 本发明还提供了使用这些化合物的方法。 最后,本发明提供包含这些化合物的药物组合物。
-
公开(公告)号:US20050267071A1
公开(公告)日:2005-12-01
申请号:US10979871
申请日:2004-11-01
申请人: Ernesto Freire , Raphael Ottenbrite , Yingxin Xiao , Adrian Velazquez-Campoy , Stephanie Leavitt , Usman Bacha , Jennifer Barrila
发明人: Ernesto Freire , Raphael Ottenbrite , Yingxin Xiao , Adrian Velazquez-Campoy , Stephanie Leavitt , Usman Bacha , Jennifer Barrila
IPC分类号: A61K20060101 , A61K31/69 , C07F5/02 , C07F5/04
CPC分类号: C07F5/025
摘要: This invention provides organic boron-containing compounds, compositions thereof, and methods of using such compounds and compositions for inhibiting coronavirus protease(s) and for treating infections.
摘要翻译: 本发明提供有机含硼化合物,其组合物,以及使用这些化合物和组合物抑制冠状病毒蛋白酶和治疗感染的方法。
-
公开(公告)号:US08318699B2
公开(公告)日:2012-11-27
申请号:US11815134
申请日:2006-01-31
IPC分类号: A61K31/405 , A61K31/135 , A61K31/225 , A61K31/69 , A61K31/09 , A61K31/216 , A61K31/352 , A61K31/15 , C07D311/82 , C07D311/94 , C07D209/12 , C07F5/02 , C07C59/31 , C07C69/353 , C07C241/00 , C07C215/20 , C07C69/76 , C07C41/01
CPC分类号: C07D493/10 , A61K31/15 , A61K31/352 , A61K31/365 , C07C251/86 , C07D311/82
摘要: The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions.
摘要翻译: 本发明涉及作为肿瘤坏死因子受体I的变构抑制剂的化合物,包含这些化合物的组合物,以及使用这些化合物及其组合物治疗TNF-α介导的病症的方法。
-
公开(公告)号:US20090221527A1
公开(公告)日:2009-09-03
申请号:US11815134
申请日:2006-01-31
IPC分类号: A61K31/69 , C07C59/31 , C07C69/353 , C07D311/82 , C07C241/00 , A61K31/09 , A61K31/216 , A61K31/222 , A61K31/352 , A61K31/15 , C07C215/20 , A61K31/135 , C07C69/76 , A61K31/225 , C07C41/01 , C07F5/02 , C07D209/12 , A61K31/405 , C07D311/94
CPC分类号: C07D493/10 , A61K31/15 , A61K31/352 , A61K31/365 , C07C251/86 , C07D311/82
摘要: The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated conditions.
摘要翻译: 本发明涉及作为肿瘤坏死因子受体I的变构抑制剂的化合物,包含这些化合物的组合物,以及使用这些化合物及其组合物治疗TNF-α介导的病症的方法。
-
-
-
-